A new trading day began on Monday, with Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) stock price up 10.17% from the previous day of trading, before settling in for the closing price of $12.69. AMLX’s price has ranged from $2.60 to $16.96 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -78.71%. Meanwhile, its annual earnings per share averaged 65.16%. With a float of $92.34 million, this company’s outstanding shares have now reached $109.77 million.
Amylyx Pharmaceuticals Inc (AMLX) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Amylyx Pharmaceuticals Inc is 15.92%, while institutional ownership is 92.95%. The most recent insider transaction that took place on Sep 30 ’25, was worth 430,952. In this transaction Co-Chief Executive Officer of this company sold 29,975 shares at a rate of $14.38, taking the stock ownership to the 3,325,301 shares. Before that another transaction happened on Sep 30 ’25, when Company’s Chief Legal Officer sold 8,828 for $14.58, making the entire transaction worth $128,669. This insider now owns 148,141 shares in total.
Amylyx Pharmaceuticals Inc (AMLX) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.55 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 65.16% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 33.77% during the next five years compared to -78.71% drop over the previous five years of trading.
Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) Trading Performance Indicators
Here are Amylyx Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 13.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.80, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.26 in one year’s time.
Technical Analysis of Amylyx Pharmaceuticals Inc (AMLX)
The latest stats from [Amylyx Pharmaceuticals Inc, AMLX] show that its last 5-days average volume of 1.48 million was superior to 1.31 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 52.59%.
During the past 100 days, Amylyx Pharmaceuticals Inc’s (AMLX) raw stochastic average was set at 72.88%, which indicates a significant decrease from 85.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.80 in the past 14 days, which was higher than the 0.68 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.52, while its 200-day Moving Average is $7.58. Now, the first resistance to watch is $14.68. This is followed by the second major resistance level at $15.37. The third major resistance level sits at $16.41. If the price goes on to break the first support level at $12.95, it is likely to go to the next support level at $11.91. Assuming the price breaks the second support level, the third support level stands at $11.22.
Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) Key Stats
With a market capitalization of 1.54 billion, the company has a total of 109,820K Shares Outstanding. Currently, annual sales are 87,370 K while annual income is -301,740 K. The company’s previous quarter sales were 0 K while its latest quarter income was -34,390 K.
